Hi secondsight
OOPS
- Chief Operations Officer
Company NameDE MOTU CORDIS
Dates EmployedFeb 2017 – Present
Employment Duration5 mos
LocationBrisbane, Australia
Chief Operations Officer at De Motu Cordis Pty. Ltd (DMC), a medtech startup commercially developing an advanced drug delivery system for critical care patients. The technology has the potential to significantly improve patient outcomes, reducing the long-term health costs of patients following cardiac arrest. Further products within the DMC portfolio leveraging the technology behind the critical care advanced drug delivery system include drug device combinations for improved treatment of hypoglycemia and anaphylaxis.
Co-Founder and CEO
Company NameGlucotek Inc
Dates EmployedMar 2017 – Present
Employment Duration4 mos
LocationBrisbane, Australia
Our mission is to make the management of gestational diabetes simple, non-invasive and easy, improving the lives of diabetic mothers and their babies.
Founder
Company NameFundamedtech
Dates EmployedMar 2015 – Present
Employment Duration2 yrs 4 mos
LocationMontreal, Canada Area
Fundamedtech is a niche medical technology start-up incubator specializing in complex medical device and digital health products.
While most health technology accelerators and incubators steer clear from ventures pursuing the development of complex medical technologies requiring pre-marketing authorization, this is our core focus.- Co Founder
Company NameSynaptecha
Dates EmployedJan 2016 – Present
Employment Duration1 yr 6 mos
LocationMontreal, Canada Area
Synaptecha is a medical technology startup developing smart beautifully designed medical devices to track and monitor patients with chronic illnesses- Founder
Company NameMSMx
Dates EmployedJan 2016 – Present
Employment Duration1 yr 6 mos
LocationMontreal, Canada Area
Today there is no simple effective method for diagnosing MS, there is no way of knowing upfront which treatment will be most effective for the patient and result in least side-effects, there is no quick effective means of monitoring response to treatment, treatment adherence and there is no means of being able to predict or prevent relapse, often resulting in hospital admission for treatment depending on severity. MSMx is developing a Diagnostic test with high sensitivity, specificity, strong negative and positive predictive value enabling early treatment of MS and prediction of treatment response in addition to a Wearable Integrated Digital health platform enabling real-time monitoring , trending and machine learning of personal and environmental factors correlated treatment, disease progression and relapse
Chief Operations Officer
Company NameAnteo Diagnostics
Dates EmployedJul 2016 – Feb 2017
Employment Duration7 mos
LocationAustralia
Led the operations and product commercialization for Anteo Diagnostics Limited (ASX: ADO), a global nanotechnology company developing and commercializing products for the life sciences, clinical diagnostics,medical device, energy, and bioseparations markets. The Anteo Group owns a patented nanochemistry surface engineering technology with high-value
commercial applications in protein binding and anti-body coupling, point of care devices, in-vivo medical devices, medical drug delivery, and batteries
- Forums
- ASX - By Stock
- ADO
- Ex ??? COO Tamara Mills
Ex ??? COO Tamara Mills, page-7
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $3.414K | 161.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 616353 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 0.021 |
12 | 2157550 | 0.020 |
10 | 3040767 | 0.019 |
10 | 1652665 | 0.018 |
3 | 94160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 616353 | 6 |
0.023 | 857853 | 5 |
0.024 | 1306228 | 3 |
0.025 | 214144 | 4 |
0.027 | 680612 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |